Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 4, 2004, Pages 528-531

  Lee, Jong Kang ^a   Tyan, Yeu Sheng ^a   Huang, Wen Sheng ^b  

^a Chung Shan University Hospital   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

CT; MRI; Recurrent oral cancer; Thallium 201 SPET

Indexed keywords

THALLIUM 201;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MOUTH CARCINOMA; MOUTH CAVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON EMISSION TOMOGRAPHY; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA;

EID: 1842714881     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1428-2     Document Type: Article

References (22)

1. Cancer registry annual report in Taiwan area, 1998. Department of Health. The Executive Yuan, Republic of China, December, 2001.
2. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999; 35:173-179.
3. Lapela M, Grenman R, Kurki T, Joensuu H, Leskinen S, Lindholm P, Haaparanta M, Ruotsalainen U, Minn H. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995; 197:205-211.
4. Anzai Y, Carroll WR, Quint DJ, Bradford CR, Minoshima S, Wolf GT, Wahl RL. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996; 200:135-141.
5. Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 2000; 110:1493-1497.
6. Greven KM, Williams DW 3rd, Keyes JW Jr, McGuirt WF, Watson NE Jr, Randall ME, Raben M, Geisinger KR, Cappellari JO. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994; 74:1355-1359.
7. Sinha PS, Beeby DI, Ryan P. An evaluation of thallium imaging for detection of carcinoma in clinically palpable solitary, nonfunctioning thyroid nodules. Thyroid 2001; 11:85-89.
8. Tonami N, Shuke N, Yokoyama K, Seki H, Takayama T, Kinuya S, Nakajima K, Aburano T, Hisada K, Watanabe Y. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989; 30:997-1004.
9. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990; 31:567-572.
10. Brendel AJ, Guyot M, Jeandot R, Lefort G, Manciet G. Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma. J Nucl Med 1988; 29:1515-1520.
11. 99mTc-HMPAO. Am J Neuroradiol 1991; 12:1187-1192.
12. 201Tl SPECT for evaluating head and neck cancer. Ann Nucl Med 1996; 10:105-111.
13. 201Tl SPET to predict the response to radiotherapy in patients with head and neck cancer. Nucl Med Commun 1996; 17:935-942.
14. Gregor RT, Valdes Olmos R, Koops W, Balm AJ, Hilgers FJ, Hoefnagel CA. Preliminary experience with thallous chloride Tl 201-labeled single-photon emission computed tomography scanning in head and neck cancer. Arch Otolaryngol Head Neck Surg 1996; 122:509-514.
15. Valdes Olmos RA, Balm AJ, Hilgers FJ, Koops W, Loftus BM, Tan IB, Muller SH, Hoefnagel CA, Gregor RT. Thallium-201 SPECT in the diagnosis of head and neck cancer. J Nucl Med 1997; 38:873-879.
16. Mukherji SK, Gapany M, Phillips D, Neelon B, O'Brien S, McCartney W, Buejenovich S, Parekh JS, Noordzij JP, Castillo M. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 1999; 20:1215-1220.
17. AJCC cancer staging manual, 5th edn. Philadelphia: Lippincott-Raven, 1997.
18. 201Tl-K-contents and Na, K-ATPase activities of tissue. Radioisotopes 1983; 32:626-628.
19. Kume N, Suga K, Nishigauchi K, Kawamura M, Matsunaga N. Relationship between thallium-201 uptake and tumour proliferative ability in thyroid nodules. Eur J Nucl Med 1996; 23:376-382.
20. Sessler MJ, Geck P, Maul FD, Hor G, Munz DL. New aspects of cellular thallium uptake: Tl+-Na+-2Cl(-)-cotransport is the central mechanism of ion uptake. Nuklearmedizin 1986; 25:24-27.
21. 201Tl in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987; 12:567-572.
22. 201Tl as a tumour-localizing agent: current status and future considerations. Nucl Med Commun 1993; 14:96-103.